Additionally, the intensity of the treatment for T2D determined the odds of still meeting the ADA criteria: T2D with oral antidiabetic medication (OR 3.16; 95% CI, 2.53–3.95; p < .001), T2D with oral antidiabetic medication plus insulin (OR 7.00; 95% CI, 5.44–9.00; p < .001) and T2D with insulin (OR 8.39; 95% CI, 6.09–11.56; p < .001) (Table 2, part D). This evidence concerns the gene INS and type 2 diabetes mellitus.